In other countries
The same active substances on other registers, the same brand first.
- Apo-PomalidomideCanada · 1 MG · Capsule · Apotex INCSame form
- Apo-PomalidomideCanada · 4 MG · Capsule · Apotex INCSame form
- Apo-PomalidomideCanada · 2 MG · Capsule · Apotex INCSame form
- ImnovidItaly · Capsula rigida · Bristol-Myers Squibb Pharma EeigSame form
- Pomalidomide AbdiItaly · Capsula rigida · Abdi Farma GmbHSame form
- Pomalidomide AccordItaly · Capsula rigida · Accord Healthcare, S.L.U.Same form
- Imnovid 1 mg, harde capsulesNetherlands · Capsule, hard · Bristol-Myers Squibb Pharma EEIGSame form
- Imnovid 2 mg, harde capsulesNetherlands · Capsule, hard · Bristol-Myers Squibb Pharma EEIGSame form
- Imnovid 3 mg, harde capsulesNetherlands · Capsule, hard · Bristol-Myers Squibb Pharma EEIGSame form
- PomolideNew Zealand · Cap 1 mgSame form
- PomolideNew Zealand · Cap 3 mgSame form
- PomolideNew Zealand · Cap 2 mgSame form
- IMNOVID 4 mgRomania · 4mg · caps. · Celgene Europe B.V.Same form
- Imnovid®Serbia · 1mg · kapsula, tvrda · Amicus SRB D.O.O.Same form
- Imnovid®Serbia · 3mg · kapsula, tvrda · Amicus SRB D.O.O.Same form
- Imnovid®Serbia · 2mg · kapsula, tvrda · Amicus SRB D.O.O.Same form
- IMNOVID 1 mg capsuleSaudi Arabia · Celgene InternationalSame form
- IMNOVID 2 mg capsuleSaudi Arabia · Celgene InternationalSame form
- IMNOVID 3 mg capsuleSaudi Arabia · Celgene InternationalSame form
- Pomagen Capsules 1MGSingapore · 1 mg · capsule · Lotus International Pte. LTD.Same form
- Pomagen Capsules 2MGSingapore · 2.0 mg · capsule · Lotus International Pte. LTD.Same form
- Pomagen Capsules 3MGSingapore · 3.0 mg · capsule · Lotus International Pte. LTD.Same form
- PomalidomideUnited States · 1MG, 2MG, 3MG … · capsule · MylanSame form
- PomalystUnited States · 1MG, 2MG, 3MG … · capsule · BristolSame form
- PomalidomideUnited States · 1MG, 2MG, 3MG … · capsule · Sun Pharmaceutical Industries LimitedSame form
- PomalystBrazil · Bristol-Myers Squibb Farmacêutica LtdaSame substance
- Imnovid (previously Pomalidomide Celgene)European Union · Bristol-Myers Squibb Pharma EEIGSame substance
- Pomalidomide AccordEuropean Union · Accord Healthcare S.L.U.Same substance
- Pomalidomide KrkaEuropean Union · Krka, d.d., Novo mestoSame substance
- ImnovidCroatiaSame substance
- Pomalidomid AccordCroatiaSame substance
- Pomalidomid TevaCroatiaSame substance
- Pomado Capsule 3 mgTaiwan · 膠囊劑 · 台灣東洋藥品工業股份有限公司Same substance
- Pomali Capsule 1mgTaiwan · 膠囊劑 · 美時化學製藥股份有限公司Same substance
- Pomali Capsule 2mgTaiwan · 膠囊劑 · 美時化學製藥股份有限公司Same substance
Packs
| Pack | Code | Status |
|---|---|---|
| POMALIDOMIDA EUGIA 4 MG CAPSULAS DURAS EFG, 21 cápsulas | 767424 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Pomalidomide
- Strength
- 4 mg
- Dosage form
- cápsula dura
- Route
- vía oral
- Register
- Spain (AEMPS)
- Status
- Marketed
- Status in the register
- Autorizado, comercializado
- Authorised
- 28 Aug 2025
- Registration
- 90270
- Marketing authorisation holder
- Eugia Pharma (Malta) Limited
- Procedure
- National, MRP or DCP
- Supply
- Uso Hospitalario